Nurix Therapeutics (NRIX) Capital Expenditures Growth (1y) (2020 - 2026)
Nurix Therapeutics (NRIX) Capital Expenditures Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Nurix Therapeutics |
1.93 Bn |
1.39 Bn |
- |
-12.63% |
| Date | Value |
|---|
| Feb 28, 2026 |
-12.63% |
| Nov 30, 2025 |
464.47% |
| Aug 31, 2025 |
-80.18% |
| May 31, 2025 |
88.03% |
| Feb 28, 2025 |
-58.53% |
| Nov 30, 2024 |
140.61% |
| Aug 31, 2024 |
88.96% |
| May 31, 2024 |
-223.96% |
| Feb 29, 2024 |
26.66% |
| Nov 30, 2023 |
-1,368.56% |
| Aug 31, 2023 |
386.56% |
| May 31, 2023 |
58.02% |
| Feb 28, 2023 |
3.17% |
| Nov 30, 2022 |
-121.19% |
| Aug 31, 2022 |
-516.81% |
| May 31, 2022 |
896.72% |
| Feb 28, 2022 |
230.39% |
| Nov 30, 2021 |
-58.38% |
| Aug 31, 2021 |
116.26% |
| May 31, 2021 |
-103.78% |
